German companies filed a 337 investigation application for a specific composite medium-sized bulk container. According to the Ministry of Commerce, on December 5, 2024, German Schütz Container Systems,Inc and Protechna S.A filed an application with the US International Trade Commission in accordance with Section 337 of the US Tariff Act of 1930. Accused that certain composite intermediate bulk containers exported to, imported from or sold in the United States infringed their patent rights, requested to initiate 337 investigation, and issued general exclusion orders, limited exclusion orders and prohibition orders. Five enterprises in China were involved in the case.The dairy sector strengthened, panda dairy products rose by 20CM, Liguo food rose by more than 17%, and western animal husbandry, knight dairy, Happy Family and Pinwo food all rose by more than 10%.FTSE China A50 index futures are now down 1% in short-term diving.
Guosen Securities' Golden Sun trading software crashed again.Topcon is reported to have received an offer from KKR and EQT.Robot concept stocks continue to be active, and many stocks such as Sinoresearch Technology have daily limit. The popular stock Taier shares have 9 consecutive boards, and Eft has increased by more than 3 times since November. In addition, Sinoresearch, Fenda Technology, Astar, construction industry, Tianqiao Lifting and Giant Wheel Intelligent have daily limit, and Huachangda, Sanfeng Intelligent and Worth Buying have increased by more than 10%.
Ubs keeps the rating of western oil companies neutral.The yield of the bank's "two permanent bonds" dropped sharply, with the yield of "24 Shanghai Pudong Development Bank Tier 2 Capital Bond 01A" dropping by 5.5bp and that of "24 Bank of Communications Tier 2 Capital Bond 02A" dropping by 8bp.The two departments issued a document: improve the working mechanism of centralized procurement and implementation of medicines. Recently, the National Medical Insurance Bureau and the National Health and Health Commission issued the Notice on Improving the Working Mechanism of Centralized Procurement and Implementation of Medicines. On the basis of the original policy, the Notice further improves the centralized procurement and implementation mechanism of medicines, guides medical institutions and pharmaceutical enterprises to follow and support the centralized procurement mechanism, and consolidates and deepens the reform results of centralized procurement of medicines and medical consumables, so that more patients can benefit. The "Notice" focuses on the detailed measures from the aspects of admission, use, monitoring, assessment and feedback of centralized drug consumables, which reflects the policy orientation of coordinated supervision between departments and preferential use of selected products. (CCTV News)